CRESTONE, INC.

DBA: CRESTONE INC

BOULDER, COLORADO 803013203

$41.82M
Total Contract Value
28 awards
First Award
Sep 20, 2022
Last Award
Nov 26, 2025
Business Size
small
CAGE Code
5RDJ6

Contract Awards

14 awards found

36C25924P1167
Department of Veterans Affairs
$-31.53
Nov 26, 2025

SYNTHESIS AND TESTING LABORATORY SERVICES FOR RESEARCH-ADD LINE ITEM DATA VALUES REQUIRED

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2026
75N93020C00020
Department of Health and Human Services
$-1
Sep 4, 2025

TO DEOBLIGATE FY 2020 5TH YEAR FUNDS ON LINE 1. TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2025
75N93019C00056
Department of Health and Human Services
$3.33M
Jun 25, 2025

TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75N93019C00056
Department of Health and Human Services
$573K
Dec 3, 2024

TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75N93020C00020
Department of Health and Human Services
$1.58M
Nov 26, 2024

TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2025
36C25924P1167
Department of Veterans Affairs
$99K
Aug 7, 2024

SYNTHESIS AND TESTING LABORATORY SERVICES FOR RESEARCH

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93019C00056
Department of Health and Human Services
$4.60M
Aug 1, 2024

TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93020C00020
Department of Health and Human Services
$971K
Jun 7, 2024

TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N93020C00020
Department of Health and Human Services
$2.67M
Aug 31, 2023

TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
36C25923P1093
Department of Veterans Affairs
$102K
Aug 17, 2023

SYNTHESIS AND TESTING OF NOVEL ANTIBIOTIC CHEMICAL COMPOUNDS FOR ROCKY MOUNTAIN REGIONAL VA MEDICAL CENTER RESEARCH DEPARTMENT

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75N93019C00056
Department of Health and Human Services
$3.51M
Jul 20, 2023

TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75N93020C00020
Department of Health and Human Services
$141K
Sep 29, 2022

TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022
75N93019C00056
Department of Health and Human Services
$4.52M
Sep 20, 2022

TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022
75N93020C00020
Department of Health and Human Services
$5.77M
Sep 20, 2022

TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022

Business Details

UEI
EDSLAP2J1BL8
CAGE Code
5RDJ6
Address
6075 LONGBOW DR STE 130
STE 130
BOULDER, CO 803013203
Congressional District
CO-02

Parent Company

CRESTONE, INC.

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov